Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects
Status:
Completed
Trial end date:
2020-07-02
Target enrollment:
Participant gender:
Summary
This study will evaluate how the test medicine DNDI-0690 is taken up and broken down by the
body and will also look at the safety and tolerability of the test medicine after a single
dose. This is the first time the test medicine DNDI-0690 will be administered to humans.